Laboratory studies on cefazolin--anti-inflammatory agent combinations with particular reference to tiaramide.
D000284:Administration, Oral; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000378:metabolism; D001412:Bacillus subtilis / Q000187:drug effects; D001591:Benzydamine / Q000008:administration & dosage; D001681:Biological Assay; D002437:Cefazolin / Q000008:administration & dosage* / Q000097:blood / Q000378:metabolism; D002511:Cephalosporins / Q000008:administration & dosage*; D005122:Exudates and Transudates / Q000032:analysis; D006099:Granuloma / Q000378:metabolism; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D010879:Piperazines / Q000008:administration & dosage*; D011817:Rabbits; D051381:Rats; D013844:Thiazoles / Q000008:administration & dosage*
D000893:Anti-Inflammatory Agents; D002511:Cephalosporins; D010879:Piperazines; D013844:Thiazoles; D001591:Benzydamine; D002437:Cefazolin